CoChat

Safety Evaluation of AAV2-GDNF Gene Transfer into the Dopaminergic Nigrostriatal Pathway in Aged and Parkinsonian Rhesus Monkeys

Open access
Su, Xiaomin, Kells, Adrian P., Huang, Eric J., Lee, Han S., Hadaczek, Piotr, Beyer, Janine, Bringas, John, Pivirotto, Philip, Penticuff, Janine, Eberling, Jamie, Federoff, Howard J., Forsayeth, John, Bankiewicz, Krystof S. · 2009 · Human Gene Therapy
Cited by 112

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

We evaluated neuropathological findings in two studies of AAV2-GDNF efficacy and safety in naive aged (>20 years) or MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-lesioned rhesus macaques. In the first study, a total of 17 animals received one of two doses of AAV2-GDNF into either putamen or substantia nigra (SN). To control for surgical variables, all animals received identical putaminal and nigral infusions in which phosphate-buffered saline was substituted for vector as appropriate. All 17 aged monkeys were studied for 6 months before necropsy. In a separate study, 11 MPTP-lesioned rhesus macaques with extensive lesions in the right SN and mild lesions in the left SN received bilateral infusions of AAV2-GDNF (9.9 x 10(11) vector genomes) or PBS into the putamen and were then studied for up to 14 months. In the current analysis, we addressed safety issues regarding AAV2-GDNF administration. An extensive series of assessments of in-life behavioral and clinical parameters was conducted. No overt histopathology or immune responses were detected in any experimental monkey. However, the delivery of AAV2-GDNF to the SN of aged monkeys caused a marked and significant loss of body weight (-19.4%). No weight loss was observed in the MPTP-lesioned monkeys despite bilateral axonal transport of glial cell line-derived neurotrophic factor (GDNF) to the SN from the putamen. These findings indicate that putaminal administration of AAV2-GDNF by convection-enhanced delivery shows therapeutic promise without any apparent side effects. Importantly, nigral administration of AAV2-GDNF caused significant weight loss that raises substantial concern for clinical application of this approach.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/hum.2009.103

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 28

  1. 10.1006/exnr.2000.7408 · DOI · Paper page
  2. 10.1016/S0006-8993(01)03253-X · DOI
  3. 10.1038/mt.2008.111 · DOI · Paper page
  4. 10.1002/glia.1107 · DOI · Paper page
  5. 10.1089/hum.2008.201 · DOI · Paper page
  6. 10.1016/S0006-8993(98)00710-0 · DOI
  7. 10.1007/s12035-008-8043-y · DOI
  8. 10.1523/JNEUROSCI.20-09-03182.2000 · DOI · Paper page
  9. Grondin R., 2003, J. Neurosci., 23, 1974, 10.1523/JNEUROSCI.23-05-01974.2003 · DOI · Paper page
  10. 10.1177/01926230701481899 · DOI · Paper page
  11. 10.1089/hum.2008.137 · DOI · Paper page
  12. 10.1016/0304-3940(81)90400-6 · doi:10.1016/0304-3940(81)90400-6
  13. 10.1016/0006-8993(94)01366-P · DOI · Paper page
  14. 10.1073/pnas.0810682106 · DOI · Paper page
  15. 10.1126/science.290.5492.767 · DOI · Paper page
  16. 10.1002/ana.20737 · DOI · Paper page
  17. 10.1038/mt.2009.45 · DOI · Paper page
  18. 10.1016/S0006-8993(02)03694-6 · DOI
  19. 10.1111/j.1460-9568.1996.tb01293.x · DOI
  20. 10.1016/S0197-4580(02)00022-2 · DOI
  21. 10.1002/cne.10898 · DOI · Paper page
  22. 10.1212/WNL.60.1.69 · DOI · Paper page
  23. 10.1002/mds.21013 · DOI · Paper page
  24. 10.1038/nn.2136 · DOI · Paper page
  25. 10.1016/S0074-7742(07)82005-8 · DOI · Paper page
  26. 10.1038/sj.gt.3302377 · DOI
  27. 10.1016/j.neurobiolaging.2005.03.018 · DOI
  28. Zhang Z., 1997, J. Pharmacol. Exp. Ther., 282, 1396, 10.1016/S0022-3565(24)36963-0 · DOI

Cited by

Metadata

Authors
Su, X., Kells, A. P., Huang, E. J., Lee, H. S., Hadaczek, P., Beyer, J., Bringas, J., Pivirotto, P., Penticuff, J., Eberling, J., Federoff, H. J., Forsayeth, J., & Bankiewicz, K. S.
Venue
Human Gene Therapy
Published
2009-12
Volume
20
Issue
12
Pages
1627-1640
ISSN
  • 1043-0342 (ISSN-L)
  • 1557-7422
OpenAlex
W2081188627
Cited by
112
References
5
FWCI
6.59
Type
journal article
Language
en
Open access
green
Licence
www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.